このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
ResMed バランスシートの健全性
財務の健全性 基準チェック /66
ResMedの総株主資本は$4.6B 、総負債は$1.0Bで、負債比率は21.7%となります。総資産と総負債はそれぞれ$6.8Bと$2.2Bです。 ResMedの EBIT は$1.3Bで、利息カバレッジ比率23.6です。現金および短期投資は$259.4Mです。
主要情報
21.7%
負債資本比率
US$1.01b
負債
| インタレスト・カバレッジ・レシオ | 23.6x |
| 現金 | US$259.45m |
| エクイティ | US$4.63b |
| 負債合計 | US$2.18b |
| 総資産 | US$6.81b |
財務の健全性に関する最新情報
ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Apr 30
We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Feb 06Recent updates
ResMed: Asymmetrical Value Opportunity With High Prospect Of Re-Rating
Jul 03An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 33% Undervalued
Jul 02ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Apr 30Earnings Beat: ResMed Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 30ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear
Apr 18With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
Mar 22Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future
Mar 10An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued
Feb 12Why ResMed Is One Of My Top Picks In 2024
Jan 22A First Look At ResMed
Jan 09ResMed Inc.'s (NYSE:RMD) Share Price Could Signal Some Risk
Dec 20Why You Should Care About ResMed's (NYSE:RMD) Strong Returns On Capital
Dec 06Shareholders May Find It Hard To Justify Increasing ResMed Inc.'s (NYSE:RMD) CEO Compensation For Now
Nov 10Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 41%?
Nov 01ResMed: Weight-Loss Drug Worries Provide Buying Opportunity
Oct 28ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity
Sep 12ResMed Has Become A Steal (Rating Upgrade)
Aug 10ResMed's (NYSE:RMD) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 07ResMed (NYSE:RMD) Has Some Way To Go To Become A Multi-Bagger
Jul 30Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Jul 16Compound Your Wealth With ResMed
Jul 04A Look At The Fair Value Of ResMed Inc. (NYSE:RMD)
Jul 02We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26ResMed (NYSE:RMD) Could Be Struggling To Allocate Capital
Apr 24Here's Why ResMed (NYSE:RMD) Has Caught The Eye Of Investors
Apr 09A Look At The Intrinsic Value Of ResMed Inc. (NYSE:RMD)
Mar 26ResMed goes ex dividend tomorrow
Feb 07ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Feb 06ResMed: The GARP Story Continues, Technicals Showing Vital Signs
Jan 26Why The 23% Return On Capital At ResMed (NYSE:RMD) Should Have Your Attention
Jan 23We Ran A Stock Scan For Earnings Growth And ResMed (NYSE:RMD) Passed With Ease
Dec 28Calculating The Fair Value Of ResMed Inc. (NYSE:RMD)
Dec 16財務状況分析
短期負債: RMDの 短期資産 ( $2.4B ) が 短期負債 ( $773.0M ) を超えています。
長期負債: RMDの短期資産 ( $2.4B ) が 長期負債 ( $1.4B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: RMDの 純負債対資本比率 ( 16.1% ) は 満足できる 水準であると考えられます。
負債の削減: RMDの負債対資本比率は、過去 5 年間で66.1%から21.7%に減少しました。
債務返済能力: RMDの負債は 営業キャッシュフロー によって 十分にカバー されています ( 119% )。
インタレストカバレッジ: RMDの負債に対する 利息支払い は EBIT ( 23.6 x coverage) によって 十分にカバーされています。